Tag: Cancer: Cervical

Overall survival longer with cemiplimab versus single-agent chemo for recurrent disease after first-line platinum-containing chemo

Risk differences for all outcomes were attenuated over time; risk for early neonatal death disappeared

Most commonly cited reason for not receiving a timely screening was lack of knowledge

Poorest neighborhoods in New York City have cervical cancer rates 73 percent higher than wealthiest neighborhoods

Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years

Progression-free and overall survival significantly longer for patients with persistent, recurrent, metastatic cervical cancer

Negative correlations seen for cervical cancer incidence and mortality rates with the Human Development Index

Social isolation and lack of safety at home associated with distress; unmet needs also linked to treatment interruption

72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening

Decline especially noticeable among women of racial and ethnic minority groups with low incomes